Ambosys Pharmaceutical Private Limited
About Ambosys Pharmaceutical Private Limited
Data last updated:
Ambosys Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 January 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2023PTC409612.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kapil Bhardwaj and Ashok Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 133 F/F Flat No. – 12 Office No. Lsc Garg Plaza Bhera Enclave, Delhi, India – 110087.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.61 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹28,392 (net margin -3%) and EBITDA of -₹13,165 (EBITDA margin -1.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ambosys Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered Address133 F/F Flat No. – 12 Office No. Lsc Garg Plaza Bhera Enclave, Delhi, India – 110087
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ambosys Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Ambosys Pharmaceutical Private Limited, buy the company report.
Financials of Ambosys Pharmaceutical Private Limited
FY 2025 filings availableAmbosys Pharmaceutical Private Limited reported revenue of ₹9.61 Lakh (down 29% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 29% in the latest year. EBITDA fell 209% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹13,165 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹28,392 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.4% | ||
| Net Profit Margin | -3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ambosys Pharmaceutical Private Limited, buy the company report.
Board of directors of Ambosys Pharmaceutical Private Limited
Ambosys Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kapil Bhardwaj | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
| Ashok Kumar Yadav Also directs: Astra Unique Prohealth Private Limited | Director | 06 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Ambosys Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maxhold Pharmaceutical Private Limited | ₹10.08 Lakh (FY 2025) | 115.0% | Bangalore, Karnataka, India | |||
| St. Clair Systems India Private Limited | ₹10.02 Lakh (FY 2025) | -77.0% | Kolhapur, Maharashtra, India | |||
| Dgi Chemicals Private Limited | ₹10 Lakh (FY 2023) | -45.0% | Mumbai, Maharashtra, India | |||
| Spanviz Healthcare Private Limited | ₹9.92 Lakh (FY 2025) | 26.0% | Pune, Maharashtra, India | |||
| Supriya Bio-Tech Private Limited | ₹9.65 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Ambosys Pharmaceutical Private Limitedthis company | ₹9.61 Lakh (FY 2025) | -₹28,392 | -3% | -29.0% | Delhi, India | |
| Herbonation Healthcare Private Limited | ₹9.53 Lakh (FY 2025) | 104.0% | Mumbai, Maharashtra, India | |||
| Lifecover Pharmaceutical Private Limited | ₹9.51 Lakh (FY 2025) | 24.0% | Nallasopara, Maharashtra, India | |||
| Bionote India Healthcare Private Limited | ₹9.43 Lakh (FY 2025) | Gurgaon, Haryana, India | ||||
| Hasan Pharma Private Limited | ₹9.2 Lakh (FY 2025) | 15.0% | Guwahati, Assam, India | |||
| Leuchtstoffwerk (India) Private Limited | ₹9.14 Lakh (FY 2025) | -86.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Ambosys Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ambosys Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ambosys Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ambosys Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ambosys Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Ashok Kumar Yadav was appointed as Director on 06 Jan 2023.
Frequently asked questions
Ambosys Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 January 2023 (3+ years old) and is registered under CIN U24230DL2023PTC409612.
Ambosys Pharmaceutical has 2 current directors:
- Kapil Bhardwaj - Director
- Ashok Kumar Yadav - Director
The latest financial statements of Ambosys Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Ambosys Pharmaceutical is U24230DL2023PTC409612. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ambosys Pharmaceutical was incorporated on 06 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ambosys Pharmaceutical by revenue are Maxhold Pharmaceutical Private Limited, St. Clair Systems India Private Limited, Dgi Chemicals Private Limited, Spanviz Healthcare Private Limited, Supriya Bio-Tech Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Ashok Kumar Yadav was appointed as Director on 06 Jan 2023. Kapil Bhardwaj was appointed as Director on 06 Jan 2023.
The registered office of Ambosys Pharmaceutical is at 133 FF Flat No. – 12 Office No. Lsc Garg Plaza Bhera Enclave, Delhi, India – 110087.
Ambosys Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Ambosys Pharmaceutical is compliant as of 14 July 2026. The company is actively filing with the Registrar of Companies.
Ambosys Pharmaceutical can be reached at its registered office: 133 FF Flat No. – 12 Office No. Lsc Garg Plaza Bhera Enclave, Delhi, India – 110087.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
